BDSX vs. CRNC

In the year-to-date period, BDSX achieves a -80.33% return, which is significantly lower than CRNC's 11.72% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Biodesix, Inc. (BDSX) and Cerence Inc. (CRNC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BDSX Sharpe Ratio is -0.88, which is lower than the CRNC Sharpe Ratio of 0.58. The chart below compares the historical Sharpe Ratios of BDSX and CRNC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither BDSX nor CRNC has paid dividends to shareholders.

The maximum BDSX drawdown since its inception was -99.30%, roughly equal to the maximum CRNC drawdown of -98.22%. Use the drawdown chart below to compare losses from any high point for BDSX and CRNC. For additional features, visit the drawdowns tool.

Biodesix, Inc. (BDSX) has a higher volatility of 66.56% compared to Cerence Inc. (CRNC) at 27.52%. This indicates that BDSX's price experiences larger fluctuations and is considered to be riskier than CRNC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Biodesix, Inc. and Cerence Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.